Opioid agonist treatment reduces losses in quality of life and quality-adjusted life expectancy in heroin users: Evidence from real world data. Chang KC, Lee KY, Lu TH, Hwang JS, Lin CN, Ting SY, Chang CC, Wang JD. Drug Alcohol Depend. 2019 Aug 1;…

Defining a recovery-oriented cascade of care for opioid use disorder: A community-driven, statewide cross-sectional assessment. Yedinak JL, Goedel WC, Paull K, Lebeau R, Krieger MS, Thompson C, et al. (2019)  PLoS Med 16(11): e1002963. doi.or…

Opioid and Polydrug Use Among Patients in Opioid Maintenance Treatment. Carlsen SL, Lunde LH, Torsheim T. Subst Abuse Rehabil. 2020 Jan 29;11:9-18. doi: 10.2147/SAR.S221618.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996215/

Hab-o Shefa, a Persian Medicine Compound for Maintenance Treatment of Opioid Dependence: Randomized Placebo-Controlled Clinical Trial. Moosavyzadeh A, Mokri A, Ghaffari F, Faghihzadeh S, Azizi H, Jafari Hajati R, Naseri M. J Altern Complement Med…

Initiation of injectable opioid agonist treatment in hospital: A case report. McAdam M, Brar R, Young S. Drug Alcohol Rev. 2019 Dec 9. doi: 10.1111/dar.13020. Abstract https://www.ncbi.nlm.nih.gov/pubmed/31814186

Opioid use disorder and treatment: challenges and opportunities. Hoffman KA, Ponce Terashima J, McCarty D. BMC Health Serv Res. 2019 Nov 25;19(1):884. doi: 10.1186/s12913-019-4751-4.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876068/